Honey and pollen antioxidant activity


CRC for Honey Bee Products research has contributed to the discovery of new compounds in bee venom to treat aggressive types of breast cancer. Melittin, a component of honey bee venom, can suppress the growth of breast cancer cells, particularly aggressive triple-negative breast cancer. The CRC has identified an additional venom compound that protects the surrounding normal cells.